SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000912057-01-522890
Filing Date
2001-07-06
Accepted
2001-07-06 00:00:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 a2050664zs-3.txt S-3 52941
2 EXHIBIT 5.1 a2050664zex-5_1.txt EX-5.1 3694
3 EXHIBIT 23.1 a2050664zex-23_1.txt EX-23.1 660
4 EXHIBIT 23.2 a2050664zex-23_2.txt EX-23.2 562
  Complete submission text file 0000912057-01-522890.txt   59696
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-64704 | Film No.: 1676017
SIC: 2835 In Vitro & In Vivo Diagnostic Substances